BiotechTube

Liposomal amikacin for inhalation

Phase 3Completed
0 watching 0 views this week📈 Rising
74
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Cystic Fibrosis

Conditions

Cystic Fibrosis

Trial Timeline

Oct 5, 2012 → Jul 16, 2015

NCT ID
NCT01316276

About Liposomal amikacin for inhalation

Liposomal amikacin for inhalation is a phase 3 stage product being developed by Insmed for Cystic Fibrosis. The current trial status is completed. This product is registered under clinical trial identifier NCT01316276. Target conditions include Cystic Fibrosis.

Hype Score Breakdown

Clinical
27
Activity
18
Company
7
Novelty
9
Community
10

Clinical Trials (2)

NCT IDPhaseStatus
NCT01316276Phase 3Completed
NCT05999942Phase 1Completed

Competing Products

20 competing products in Cystic Fibrosis

See all competitors
ProductCompanyStageHype Score
VX-522 mRNA therapy + IVAModernaPhase 1/2
38
Tildacerfont + PlaceboSpruce BiosciencesPhase 2
44
Enfortumab VedotinAstellas PharmaPhase 2
52
CefiderocolShionogiApproved
85
LenvatinibEisaiPhase 2
52
Lenvatinib + PembrolizumabEisaiPhase 2
52
CREONAbbVieApproved
85
Pancrelipase + PancrelipaseAbbVieApproved
85
Creon IR + Creon® (DR/GR)AbbViePhase 2
52
ABBV-CLS-628 + PlaceboAbbViePhase 2
52
Elagolix + PlaceboAbbViePhase 2
52
ABBV-3067 + Placebo ABBV-3067 + ABBV-2222 + Placebo ABBV-2222AbbViePhase 2
52
ABBV-576 + Galicaftor + Placebo + Navocaftor + ABBV-119AbbViePhase 2
52
Benralizumab + Placebo to BenralizumabAstraZenecaPhase 3
77
AZD5634 for inhalation + AZD5634 for infusionAstraZenecaPhase 1
33
Metformin XR + Saxagliptin + Saxagliptin-Metformin XRAstraZenecaPhase 3
77
AZD1236 + PlaceboAstraZenecaPhase 2
52
Exenatide once weekly (EQW ) + Dapagliflozin (DAPA) + EQW plus DAPA + Dapagliflozin plus Glucophage (MET ER) + Phentermine /Topiramate (PHEN/ TPM) ERAstraZenecaPhase 3
77
AZD1613 - Part A + Placebo - Part A + AZD1613 - Part B + Placebo - Part BAstraZenecaPhase 1
33
AZD9668 + AZD9668 Placebo equivalentAstraZenecaPhase 2
52

Other Products from Insmed

Liposomal amikacin for inhalation (Arikayce™) using the PARI Investigational eFlow® Nebulizer. + Tobramycin inhalation solution using a PARI LC® Plus nebulizer.Phase 3
74
Treprostinil Palmitil Inhalation Powder + PlaceboPhase 3
74
Treprostinil Palmitil Inhalation Powder + PlaceboPhase 3
74
ALIS + Azithromycin + Ethambutol + ELCPhase 3
74
LAI 590 mg + Multi-drug regimenPhase 3
74